© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Cycloheximide, with the molecular formula C15H23NO4, sits among the more potent inhibitors in biology labs and industrial production lines. This compound belongs to the class of glutarimide antibiotics, which means it is not just any chemical but one with a precise role in stopping protein synthesis in eukaryotic organisms. Its primary form is a white to off-white solid, showing up as flakes, crystalline powder, or sometimes as fine pearls. Cycloheximide reaches its melting point between 119°C and 121°C, and it dissolves exceptionally well in acetone, ethanol, and methanol, offering flexibility for researchers grappling with complex solutions. The density comes close to 1.13 g/cm³, leaving little confusion about how much space one gram occupies in a standard flask or beaker. Trusted sources place its HS Code as 2930907000, marking it out in global trade for easy tracking and regulation.
This compound steps onto the world stage mostly in crystal and powder forms, rarely as a liquid or other variation. Cycloheximide is fundamentally a tool for life sciences—screening for fungus in crops, protecting cell cultures, and cutting out unwanted protein synthesis in research settings. While talking with researchers, I’ve learned that no other compound provides quite the same punch with such small concentrations. At levels as low as 0.1 μg/mL, it manages to halt the activity of ribosomes almost completely. That level of control is why laboratories prize it, but it also raises flags for those who need to protect against unintended toxicity. The flakes dissolve neatly, make dosage preparation relatively straightforward, and have a marked stability under standard lab conditions. Cycloheximide’s stability lasts up to two years if stored in a cool, dry place, away from light and moisture.
Cycloheximide features a single chiral center, and its structure showcases a six-membered ring attached to distinct hydrocarbon chains and polar functional groups. This setup lets it bind with ribosomal subunits, creating an environment where protein assembly shuts down almost instantly. One glance at a drawn-out structure and its molecular weight—281.35 g/mol—shows how tightly packed the atoms behave, reinforcing its dense packing in crystalline or powder form. Cycloheximide lacks significant volatility, so direct inhalation in open air rarely becomes a concern unless someone mishandles pure powder or solution.
Anyone touching this compound needs to know Cycloheximide counts as hazardous. Exposure, either by breathing the dust, letting it touch skin, or by ingestion, brings about real risks. Symptoms can show up as dizziness, nausea, skin irritation, or more serious internal toxicity. Over years in lab environments, the warnings from safety officers become almost automatic: gloves, lab coats, and face shields for open transfers. If a spill happens, vacuuming up solid particles with specialized equipment, not sweeping them up or allowing dust clouds, protects everyone in the lab. Cycloheximide holds a place on the list of chemicals that institutions track rigorously, especially as its effects on non-target organisms come heavily documented in academic journals. Its manufacture and use sometimes invite regulatory checks, with authorities in Europe, North America, and parts of Asia limiting its sale and requiring proof of intended legal use.
Manufacturers typically ship cycloheximide in sealed bottles or drums, usually ranging from small multi-gram vials for academic researchers up to multi-kilogram drums for industrial or agricultural applications. Each container carries specification sheets detailing purity (usually ≥98%), molecular structure, CAS number (66-81-9), and crystal habit observation for cross-reference. Flakes and powder both reach users, but most stick to powder for its easier blending within aqueous or alcoholic solutions. Safety sheets, required by law, travel with every shipment—these documents walk users through recommended storage (below 8°C, low humidity), correct disposal procedures, and first-aid routines if contamination occurs. From my work with chemical suppliers, I’ve noticed those handling raw material often encounter cost spikes and delivery delays, a direct result of the heavy regulation on controlled chemicals.
The supply chain behind cycloheximide rests on select raw materials like proline, acetic anhydride, and various reagents only available in countries with advanced chemical industries. Sourcing quality precursors limits the opportunity for impurities—one misstep at the raw material stage can mean failed synthesis, wasted labor, and failed safety standards down the line. Fluctuations in access to these raw materials from Asia or the European Union, driven by export policy or environmental review, make the market for cycloheximide unpredictable. Price jumps and backorders remain common, and researchers can get caught in months-long waits if global trade takes a hit.
One of the pressing concerns with cycloheximide, aside from its routine hazards, links back to its persistence in the environment. Once it exits a controlled environment, it impacts aquatic life, disrupts non-target fungi, and traces can pass into water tables if not disposed by experts. Proper incineration, and not simply dumping or pouring down the drain, stands as a best practice. I have seen cases where poor handling led to fines, research audits, and at least once, a failed academic tenure review for non-compliance in university settings. Chemical companies must invest in training and upgraded waste-processing rigs to deal with such high-impact compounds. Reports from environmental watchdogs continue to highlight how improper handling of research chemicals still threatens wildlife beyond the lab door, even with official procedures in place.
Safer practices and smarter protocols can cut down on most cycloheximide-related accidents. Teams in research or industry benefit from regular retraining, double-sealed storage units, and new sensor technology that detects airborne particulate contamination. Digital logs for all high-risk raw materials—including cycloheximide—not only prevent loss or misuse but paint a clear compliance picture when inspectors ask questions. At a systems level, organizations should support replacement research, funding the hunt for alternatives that achieve the same biological results without the lasting environmental impact. Where suitable, labs can cut unnecessary stock, switching to lower-toxicity substances for basic screening, reserving cycloheximide for cases with no substitute options. My experience says that strict stewardship—personnel discipline, supply chain vigilance, and transparency—does more to curb risk and protect research continuity than any one regulation on paper.
